Targeted therapy may increase survival in pancreatic cancer: Lancet || Medical Dialogues||

By Dr. K B Aarthi Targeted therapy which targets specific molecules involved in cancer cell growth may give an extra year of survival to cancer patients.

US: Pancreatic cancer is an intractable disease that often evades early diagnosis and defies treatment.

Targeted therapy for pancreatic cancer patients may give an extra year of survival, showed by an observational study conducted at the University of Texas MD Anderson Cancer Centre, USA, published in The Lancet Oncology journal.

Read more